
Medical Writing / Automatic Clinical Protocol Generation

The CARA Life Sciences Platform includes data-to-document tools to automatically generate Clinical Protocols and Study Reports, and then edit those documents using Structured Content Authoring (Component-based Authoring)
Our CTMS provides a single source of truth for all operational Clinical Trial data and workflows. It helps Clinical Trial Managers to make operational decisions based on timely, accurate and consistent data consolidated across simultaneous workstreams like study and site initiation, patient recruitment, monitoring and drug supply.
Generate Protocols & CSRs
The unique data-to-documents capabilities of the CARA Life Science platform allow you to generate Protocols and Clinical Study Reports at the click of a mouse. The document content is assembled in a formatted state based on data and concatenation rules defined on templates, and the output document can then be manually adjusted ready for regulatory submission or eTMF use
Structured Content Authoring
Leverage the CARA Structured Content Authoring (also known as component-based authoring) for creating documents that share common components e.g. study reports and protocols. Authors can re-use components, and get alerted when template components they used are updated, or other users have updated a shared component, and authors can then decide whether to incorporate the latest updates or not
External Collaboration
Use the tools in CARA to invite users to a time-limited access to the CARA Life Science platform to collaborate on individual document(s). This collaboration is in a secure environment with version control and auditing. The collaboration can include review or collaborative authoring, where multiple users can edit the same document at the same time
Latest Resources

Cytonics Selects CARA Life Sciences Platform for Rapid eTMF System Implementation
Cytonics, a biotechnology research and development company specializing in diagnostics and therapeutics for osteoarthritis, has selected Generis, the provider of the AI-enabled CARA Life Sciences

Kwizda Pharma Adopts CARA Life Sciences Platform for Rapid QMS Implementation with Minimal IT Resources
Kwizda Pharma, a division of Kwizda Holding GmbH and a leader in the Austrian healthcare market, has selected the CARA Life Sciences Platform from Generis,

eTMF Archive on the CARA Life Sciences Platform
eTMF Archive on the CARA Life Sciences Platform The CARA Life Sciences Platform offers a comprehensive Electronic Trial Master File (eTMF) Archive, designed to enhance
